Cargando…
Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms
Cannabinoids are used clinically on a subacute basis as prophylactic agonist antiemetics for the prevention of nausea and vomiting caused by chemotherapeutics. Cannabinoids prevent vomiting by inhibition of release of emetic neurotransmitters via stimulation of presynaptic cannabinoid CB(1) receptor...
Autor principal: | Darmani, Nissar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036650/ https://www.ncbi.nlm.nih.gov/pubmed/27713347 http://dx.doi.org/10.3390/ph3072163 |
Ejemplares similares
-
Cannabinoid hyperemesis syndrome: the conundrum is here to stay
por: Schey, Ron
Publicado: (2020) -
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting
por: Darmani, Nissar A.
Publicado: (2010) -
Cannabinoid hyperemesis syndrome with extreme hydrophilia
por: Enuh, Hilary A, et al.
Publicado: (2013) -
Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Adolescents
por: Nachnani, Rahul, et al.
Publicado: (2022) -
Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome
por: Bonnet, Udo
Publicado: (2022)